Llwytho...
Friend or foe? ACE2 inhibitors and GLP-1R agonists in COVID-19 treatment
COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a pandemic since WHO made the statement on March 11, 2020. The infection is causing a high mortality in old people, especially those with obesity, type 2 diabetes (T2D) or cardiovascular diseases (CVD). Extra...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Obes Med |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Elsevier Ltd.
2021
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7785422/ https://ncbi.nlm.nih.gov/pubmed/33426364 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.obmed.2020.100312 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|